Avloquin-H Tablet 200 mg is an antimalarial drug used to treat certain types of parasites in the body. It is also used to prevent or treat certain autoimmune diseases, such as lupus and rheumatoid arthritis.
Avloquin-H Tablet 200 mg is used to treat or prevent malaria, a disease caused by parasites that can enter the body through the bite of a mosquito. It works by preventing or treating the growth of certain parasites within the body's cells.
It may also be used to treat symptoms of rheumatoid arthritis and discoid or systemic lupus erythematosus.
| Brand Name | Avloquin-H |
|---|---|
| Type | Tablet |
| Weight | 200 mg |
| Generic | Hydroxychloroquine Sulphate |
| Manufacturer | ACI Limited |
| Available in | English বাংলা |
Avloquin-H Tablet 200 mg works by suppressing the immune system, decreasing inflammation, and preventing the growth of certain parasites within the body’s cells. It is not known exactly how it works, but it is thought to interfere with communication between cells within the immune system.
It typically takes up to three weeks for Avloquin-H Tablet 200 mg to begin working. However, the full effect may take up to three months.
Avloquin-H Tablet 200 mg is rapidly and almost completely absorbed from the gastrointestinal tract.
The major route of elimination is by the kidney, with 70-80% of the administered dose excreted in the urine, and the remainder excreted in the feces.
Dosage depends on the condition being treated, age, and weight of the patient. It is typically prescribed in either the tablet or liquid forms. Typical dosage for adults with malaria is 800 mg initially, followed by 400 mg 12 hours later, on the same day. The dosage for ongoing treatment is 400 mg daily for up to two weeks or more. The dosage for rheumatoid arthritis and lupus is 400-600 mg daily for three to four months.
Avloquin-H Tablet 200 mg can be administered orally or intravenously (IV). It is recommended to take it with food to reduce the chance of stomach upset. Do not cut, crush, or chew the tablets.
The most common side effects of Avloquin-H Tablet 200 mg include nausea, vomiting, stomach pain, diarrhea, dizziness, headache, loss of appetite, and rash. Other serious side effects may include vision changes, liver problems, and muscle weakness. Patients should contact their healthcare provider if they experience any of the above symptoms.
Avloquin-H Tablet 200 mg is moderately toxic. Overdose may lead to life-threatening conditions, such as visual impairment, vomiting, nausea, confusion, muscle weakness, seizures, and coma. Seek immediate medical attention if a Avloquin-H Tablet 200 mg overdose is suspected.
Avloquin-H Tablet 200 mg should be avoided by those with underlying kidney, liver, or heart disease, or by those with known allergies to the drug. It should not be used by pregnant or nursing women, or those planning to become pregnant, unless specifically instructed to by a doctor.
It is important to tell your doctor of any other medications or supplements you are taking, as they may interact with Avloquin-H Tablet 200 mg. This includes any over-the-counter medications, vitamins, or herbal supplements.
This medication should be used with caution in patients with a history of diabetes, lifestyle diseases (e.g., hypertension and obesity), autoimmune diseases (e.g., Crohn’s disease, rheumatoid arthritis, systemic lupus erythematosus), or those with a history of vision problems, seizures, psychiatric disorders, or liver or kidney disease.
There is a risk of potential drug interactions with Avloquin-H Tablet 200 mg. Patients should inform their doctor if they are taking other medications, such as certain antibiotics (e.g., ciprofloxacin, norfloxacin, erythromycin), antifungal medications (e.g., ketoconazole, itraconazole), nonsteroidal anti-inflammatory drugs (e.g., ibuprofen), or some antidepressant medications (e.g., fluoxetine).
Patients should avoid taking Avloquin-H Tablet 200 mg with foods high in calcium, including dairy products, antacids, or calcium supplements, as this may reduce the absorption of the medication.
Avloquin-H Tablet 200 mg should not be used by pregnant women unless the potential benefit outweighs the risk to the unborn baby. Treatment should be stopped immediately if a woman becomes pregnant while taking this medication.
It is not known if Avloquin-H Tablet 200 mg is excreted into breast milk. Therefore, nursing mothers should discuss the risks and benefits with their doctor before taking this medication.
If an acute overdose is suspected, seek medical attention immediately. Symptoms of a Avloquin-H Tablet 200 mg overdose may include nausea, vomiting, abdominal pain, loss of appetite, confusion, seizures, and coma.
Avloquin-H Tablet 200 mg should not be used by those with known allergies to the drug, or by those with underlying kidney, liver, or heart disease. It should not be used in combination with other medications. It should also not be used by pregnant or nursing women.
Avloquin-H Tablet 200 mg should be taken as directed by the healthcare provider. The dosage will depend on the condition being treated, the age and weight of the patient, and other factors.
Avloquin-H Tablet 200 mg should be stored in a tightly sealed container at room temperature. It should be kept away from light, moisture, and heat.
The volume of distribution for Avloquin-H Tablet 200 mg is 50-60 liters per kilogram.
The half-life of Avloquin-H Tablet 200 mg is approximately 3-4 days.
The clearance of Avloquin-H Tablet 200 mg is approximately 45 liters per hour.
See in details version Avloquin-H Tablet 200 mg also Avloquin-H Tablet 200 mg in bangla
Dr. Major S. M. Ashek Uddin Bhuiyan
Mental Diseases, Brain Disorder & Psychiatry Specialist